These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 49763)

  • 21. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary dapsone-resistant leprosy in Cebu, Philippines.
    Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
    Levy L; Shepard CC; Fasal P
    Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
    [No Abstract]   [Full Text] [Related]  

  • 24. Rapid test for drug resistance in leprosy.
    Ambrose EJ; Khanolkar SR; Antia NH; Chulawalla RG; Koticha KK
    Lancet; 1977 Nov; 2(8046):1036. PubMed ID: 72940
    [No Abstract]   [Full Text] [Related]  

  • 25. Primary sulphone resistance. A preliminary report.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1978 Jul; 50(3):352-5. PubMed ID: 359924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dormancy, drug resistance or dependency; some thoughts to ponder.
    Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
    Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
    Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium leprae persisters after treatment with dapsone and rifampicin.
    Pattyn SR; Dockx P; Rollier MT; Rollier R; Saerens EJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):154-8. PubMed ID: 776851
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.
    Waters MF; Pearson JM; Rees RJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850
    [No Abstract]   [Full Text] [Related]  

  • 30. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 31. The association of pregnancy and leprosy. II. Pregnancy in dapsone-resistant leprosy.
    Duncan ME; Pearson JM; Rees RJ
    Lepr Rev; 1981 Sep; 52(3):263-70. PubMed ID: 7035779
    [No Abstract]   [Full Text] [Related]  

  • 32. Survey of primary dapsone-resistant leprosy.
    Wang HY; Li WZ; Yang LH; Huang HS; Lu WQ; Yu LC
    Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(3):173-5. PubMed ID: 3321049
    [No Abstract]   [Full Text] [Related]  

  • 33. The diagnosis and management of dapsone-resistant leprosy.
    Waters MF
    Lepr Rev; 1977 Jun; 48(2):95-105. PubMed ID: 331001
    [No Abstract]   [Full Text] [Related]  

  • 34. Primary dapsone resistance in Bamako and Chingleput: final report; THELEP. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1987 Sep; 58(3):209-18. PubMed ID: 3312895
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevalence of dapsone-resistant leprosy in Burundi. Temporary results].
    Bourland J; Van Loo L; Pattyn SR
    Acta Leprol; 1982; (86-87):29-33. PubMed ID: 6815995
    [No Abstract]   [Full Text] [Related]  

  • 36. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
    Browne SG
    Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
    [No Abstract]   [Full Text] [Related]  

  • 37. The problem of dapsone-resistant leprosy.
    Pearson JM
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):417-20. PubMed ID: 7042605
    [No Abstract]   [Full Text] [Related]  

  • 38. Dapsone-resistant leprosy in Jakarta: a preliminary report.
    Utji R; Kosasih A; Santoso AU
    Lepr Rev; 1983 Sep; 54(3):193-5. PubMed ID: 6355723
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of sulphone-resistant lepromatous leprosy.
    Jopling WH
    Lepr Rev; 1977 Jun; 48(2):127-8. PubMed ID: 330998
    [No Abstract]   [Full Text] [Related]  

  • 40. Dapsone-resistant leprosy-the THELEP approach.
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):421-5. PubMed ID: 7042606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.